GALWAY, IRELAND--December 1, 2016--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--Pharmaceutical major Pfizer (NYSE:PFE) (New York, New York) has axed a planned 400 million euro ($426 million) expansion at its Irish manufacturing operations in Dublin. Within this article: Details axed projects following drug trial failure
(All Fields Required)